Related Experiment Videos
Epileptic seizures after subarachnoid hemorrhage
D Hasan1, R S Schonck, C J Avezaat
1Department of Neurology, University Hospital Rotterdam Dijkzigt, The Netherlands.
Annals of Neurology
|March 1, 1993
Summary
Subarachnoid hemorrhage (SAH) patients with high cisternal blood scores and rebleeding are at increased risk for developing epilepsy. These factors predict long-term seizure development after SAH from ruptured intracranial aneurysms.
Area of Science:
- Neurosurgery
- Neurology
- Clinical Medicine
Background:
- Subarachnoid hemorrhage (SAH) from ruptured intracranial aneurysms is a critical neurological event.
- Epilepsy is a common complication following SAH, impacting patient outcomes.
- Identifying predictive factors for post-SAH epilepsy is crucial for risk stratification and management.
Purpose of the Study:
- To investigate predictive factors for the development of epilepsy in patients following subarachnoid hemorrhage.
- To identify specific clinical and radiological indicators associated with long-term seizure occurrence after SAH.
Main Methods:
- A cohort of 381 consecutive patients admitted within 72 hours of SAH were analyzed.
- Predictive factors including demographics, clinical presentation, CT findings, and treatment interventions were assessed.
- Cox proportional hazards modeling was employed to identify significant risk factors for epilepsy development.
Main Results:
- Epileptic seizures occurred in 9% of patients, with a median onset of 18 days post-SAH.
- A high cisternal blood score on initial CT and rebleeding were significantly associated with an increased risk of epilepsy.
- These associations remained significant even after excluding patients who received prophylactic anticonvulsants.
Conclusions:
- High cisternal blood burden and rebleeding are significant independent predictors of epilepsy after aneurysmal SAH.
- These findings can aid in identifying high-risk individuals for closer monitoring and potential prophylactic strategies.
- Further research may explore targeted interventions to mitigate epilepsy risk in these vulnerable patients.